Prognosis of keratinizing squamous cell carcinoma of the female reproductive system: A retrospective study
Open Access
- 1 March 2025
- journal article
- Published by SAGE Publications in Cancer Biomarkers
- Vol. 42 (3)
Abstract
Objective: The aim of this study was to compare the competing risk model with the Cox model to evaluate prognostic markers in females with keratinized squamous cell carcinoma of the reproductive system and to develop predictive models. Methods: Patients with keratinizing squamous cell carcinoma of the female reproductive system were identified from the Surveillance, Epidemiology, and End Results (SEER) database. Using the cumulative incidence function (CIF) and Gray's test for univariate analysis, the competing risk and Cox models were used for multivariate analysis. A nomogram was developed based on the results of the competing risk model, and the C-index, net reclassification index (NRI), and integrated discrimination improvement (IDI) were used to evaluate the model's discrimination ability. The clinical validity of the model was assessed using calibration plots and decision curve analysis (DCA). Results: In this investigation, competing risk model analysis revealed that age, marital status, tumor size, AJCC stage, surgery, radiotherapy, chemotherapy, postoperative lymph node dissection, surgery and radiotherapy, and income were significant factors affecting the prognosis of patients with keratinizing squamous cell carcinoma of the female reproductive system. Based on these results, a nomogram for predicting the 3-year, 5-year, and 8-year survival rates was established. The nomogram demonstrated better clinical utility than the AJCC staging system. Conclusion: For the first time, the competing risk model was used in this study to assess the prognostic risk factors of keratinizing squamous cell carcinoma of the female reproductive system. The results may help clinicians make better clinical judgments. Additionally, we developed a nomogram to predict the likelihood of cancer-specific death (CSD) in patients at 3, 5, and 8 years. Physicians may use our nomogram to more accurately forecast the likelihood of CSD compared to the AJCC staging system.Keywords
Funding Information
- China Medical Education Association (2022KTZ009)
This publication has 30 references indexed in Scilit:
- Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry dataCancer Medicine, 2020
- Brachytherapy improves survival in primary vaginal cancerGynecologic Oncology, 2016
- Epidemiology and outcomes of squamous ovarian carcinoma; a population-based studyGynecologic Oncology, 2016
- Trends in surgery and outcomes of squamous cell vulvar cancer patients over a 16-year period (1998–2013): a population-based analysisJournal of Cancer Research and Clinical Oncology, 2016
- Survival advantage of marriage in uterine cancer patients contrasts poor outcome for widows: A Surveillance, Epidemiology and End Results studyGynecologic Oncology, 2015
- Fertility preservation in the female cancer patientJournal of Surgical Oncology, 2014
- A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification indexStatistics in Medicine, 2013
- Competing risks and the clinical community: irrelevance or ignorance?Statistics in Medicine, 2011
- Prognostic impact of marital status on survival of women with epithelial ovarian cancerPsycho-Oncology, 2011
- Prognostic significance of keratinization in squamous cell cancer of uterine cervix: a population based studyArchives of Gynecology and Obstetrics, 2008